Alumis (ALMS) Plans to Advance Envudeucitinib After LUMUS Missed in the Overall Population
Alumis Inc.
Alumis Inc. (ALMS)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 6,348,558 | $178,648,422 | -7% | 2.6% |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 6,345,219 | $178,554,463 | 14.67% | |
| 3. | Cormorant Asset Management Bihua Chen | 3,285,596 | $92,456,671 | -17% | 4.74% |
| 4. | Saturn V Capital Management Xiaoying Tian | 2,915,443 | $82,040,566 | -9% | 11.76% |
| 5. | Octagon Capital Advisors Ting Jia | 2,830,700 | $79,655,898 | 7.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.63 | 273,290 | $2,904,280.16 | 2,298,783 | 2026-09-08 | Filing | |
| $10.63 | 273,291 | $2,904,290.79 | 4,937,026 | 2026-09-08 | Filing | |
| $11.17 | 220,070 | $2,458,842.11 | 2,073,558 | 2026-09-04 | Filing | |
| $11.17 | 220,070 | $2,458,842.11 | 4,711,801 | 2026-09-04 | Filing | |
| $17.00 | 588,235 | $9,999,995.00 | 1,853,488 | 2026-01-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.55 | 48,065 | $507,008.85 | 2,025,493 | 2026-09-08 | Filing | |
| $10.55 | 48,066 | $507,019.39 | 4,663,735 | 2026-09-08 | Filing | |
| $26.37 | 3,282 | $86,546.34 | 24,718 | 2026-08-03 | Filing | |
| $26.37 | 1,364 | $35,968.68 | 9,747 | 2026-08-03 | Filing | |
| $26.37 | 2,692 | $70,988.04 | 207,746 | 2026-08-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,139,707 | $426,031,355 | 100% | |
| 2. | 8,218,151 | $231,258,771 | 0% | |
| 3. | 6,769,170 | $190,484,444 | 0.01% | |
| 4. | 5,896,995 | $165,941,439 | 45.81% | |
| 5. | 4,528,408 | $127,429,401 | 24.53% |
News See All
Top 10 Hot Stocks with the Highest Upside Potential
In this article, we will be taking a look at the Top 10 Hot Stocks with the Highest Upside Potential.
10 Under-the-Radar Stocks with Massive Upside for 2026
In this piece, we discuss the 10 Under-the-Radar Stocks with Massive Upside for 2026. The earnings season, which carried equities to record highs, is largely over.
10 Best Performing Stocks of Q1 2026 to Watch for Q2
In this article, we will be looking at the 10 Best Performing Stocks of Q1 2026 to Watch for Q2.
Chardan Highlights Alumis’s (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials
Alumis Inc. (NASDAQ:ALMS) is one of the new stocks on the rise.
10 New Stocks on the Rise
On January 21, Lynn Martin, NYSE president, joined CNBC's Sara Eisen to discuss the IPO landscape for 2026.
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating
Alumis Inc. (NASDAQ:ALMS) is among the 14 best booming stocks to buy right now. On January 9, HC Wainwright & Co.
14 Best Booming Stocks to Buy Right Now
This article looks at the 14 Best Booming Stocks to Buy Right Now.
11 Best New Penny Stocks to Buy Right Now
On July 28, the Opening Bid team at Yahoo Finance and Victoria Fernandez, chief market strategist at Crossmark Global Investments, discussed the rise in cheap stock trading and what it can mean for the...
Morgan Stanley Resumes Coverage of Alumis (ALMS) with $23 PT
On Monday, Morgan Stanley resumed its coverage of Alumis Inc.
Hedge Fund Resource Center